ATE430585T1 - Zusammensetzung zur oralen oder rektalen verabreichung - Google Patents

Zusammensetzung zur oralen oder rektalen verabreichung

Info

Publication number
ATE430585T1
ATE430585T1 AT03703650T AT03703650T ATE430585T1 AT E430585 T1 ATE430585 T1 AT E430585T1 AT 03703650 T AT03703650 T AT 03703650T AT 03703650 T AT03703650 T AT 03703650T AT E430585 T1 ATE430585 T1 AT E430585T1
Authority
AT
Austria
Prior art keywords
composition
suppository
tablet
oral
food supplement
Prior art date
Application number
AT03703650T
Other languages
English (en)
Inventor
Bengt Hersloef
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE430585T1 publication Critical patent/ATE430585T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • General Preparation And Processing Of Foods (AREA)
AT03703650T 2002-02-15 2003-02-14 Zusammensetzung zur oralen oder rektalen verabreichung ATE430585T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0200475A SE0200475D0 (sv) 2002-02-15 2002-02-15 Oral farmaceutisk beredning
PCT/SE2003/000251 WO2003068267A1 (en) 2002-02-15 2003-02-14 Composition for oral or rectal administration

Publications (1)

Publication Number Publication Date
ATE430585T1 true ATE430585T1 (de) 2009-05-15

Family

ID=20286999

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03703650T ATE430585T1 (de) 2002-02-15 2003-02-14 Zusammensetzung zur oralen oder rektalen verabreichung

Country Status (20)

Country Link
US (1) US20050181042A1 (de)
EP (1) EP1474174B1 (de)
JP (1) JP2005520816A (de)
KR (1) KR20040089633A (de)
CN (1) CN101060862A (de)
AT (1) ATE430585T1 (de)
AU (1) AU2003206355B2 (de)
BR (1) BR0313651A2 (de)
CA (1) CA2475025C (de)
DE (1) DE60327511D1 (de)
DK (1) DK1474174T3 (de)
ES (1) ES2324603T3 (de)
MX (1) MXPA04007946A (de)
NZ (1) NZ534812A (de)
PT (1) PT1474174E (de)
RU (1) RU2302260C2 (de)
SE (1) SE0200475D0 (de)
SI (1) SI1474174T1 (de)
WO (1) WO2003068267A1 (de)
ZA (1) ZA200406399B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
SE0400233D0 (sv) * 2004-02-04 2004-02-04 Ltp Lipid Technologies Provide Rektal komposition
EA012882B1 (ru) * 2005-04-28 2009-12-30 ДСМ АйПи ЭССЕТС Б.В. Фармацевтические лекарственные формы, содержащие липидную фазу
WO2007098446A2 (en) * 2006-02-21 2007-08-30 Accu-Break Pharmaceuticals, Inc. Method for minimizing variation in dosage forms
CN101278928B (zh) 2007-04-06 2011-09-07 常州高新技术产业开发区三维工业技术研究所有限公司 含左卡尼汀或其衍生物的药物组合物及其用途
CN101991557B (zh) * 2009-08-10 2013-09-18 杭州赛利药物研究所有限公司 一种盐酸万古霉素液体胶囊及其制备方法
WO2012144943A1 (en) * 2011-04-18 2012-10-26 Lipidor Ab Liquid carrier for oral delivery of a pharmacologically active agent
US10117885B2 (en) * 2011-08-11 2018-11-06 Allergy Research Group, Llc Chewable lipid supplements for treating pain and fibromyalgia
CN102631290A (zh) * 2012-04-05 2012-08-15 韩昌志 一种生产栓剂的综合法
US10456327B2 (en) 2015-08-28 2019-10-29 Craig Robertson Package for frozen nutrient pill

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7812466A (nl) * 1978-12-22 1980-06-24 Shell Int Research Werkwijze voor de bereiding van gasmengsels.
DE2951142C2 (de) * 1979-12-19 1983-11-03 A. Nattermann & Cie GmbH, 5000 Köln Suppositorium-Zubereitung von Indometacin oder Acemetacin
US4966776A (en) * 1983-04-11 1990-10-30 Board Of Regents, The University Of Texas System Compositions and methods of treating calcium renal stones
US4699776A (en) * 1985-06-28 1987-10-13 R. P. Scherer Corporation Suppositories containing analgesics, antipyretics or anti-inflammatory agents
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
AU645003B2 (en) * 1988-11-08 1994-01-06 Takeda Chemical Industries Ltd. Sustained release preparations
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
EP0664701B1 (de) * 1992-10-16 1997-09-10 Glaxo Group Limited Geschmacksmaskierende zusammensetzungen von ranitidin
US5505982A (en) * 1994-01-28 1996-04-09 Fmc Corporation Chocolate confection
CA2182577C (en) * 1994-02-04 2002-08-20 Anders Carlsson Lipophilic carrier preparations
JP2948111B2 (ja) * 1994-09-16 1999-09-13 塩野義製薬株式会社 経口投与用油性組成物
DE29511421U1 (de) * 1995-07-14 1995-10-12 Chou, Wen San, An Ting, Tainan Luftkompressor
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
EP1022019A4 (de) * 1997-10-08 2006-07-19 Taisho Pharmaceutical Co Ltd Zäpfchenzusammensetzung
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
EP1043016B1 (de) * 1999-03-30 2014-08-20 Sodic Sa Pflanzenextrakt auf Glycerid-, Phospholipid- und Phytosphingolipidbasis, Verfahren für die Gewinnung dieses Extrakts und ihn enthaltende kosmetische Zusammensetzungen
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
JP4116436B2 (ja) * 2000-12-14 2008-07-09 エフ．ホフマン−ラ ロシュ アーゲー 自己乳化脂質マトリックス（ｓｅｌｍ）

Also Published As

Publication number Publication date
EP1474174A1 (de) 2004-11-10
SE0200475D0 (sv) 2002-02-15
DK1474174T3 (da) 2009-07-06
US20050181042A1 (en) 2005-08-18
AU2003206355A1 (en) 2003-09-04
NZ534812A (en) 2006-10-27
RU2302260C2 (ru) 2007-07-10
DE60327511D1 (de) 2009-06-18
PT1474174E (pt) 2009-06-25
ES2324603T3 (es) 2009-08-11
BR0313651A2 (pt) 2008-11-11
ZA200406399B (en) 2005-09-12
CA2475025A1 (en) 2003-08-21
KR20040089633A (ko) 2004-10-21
EP1474174B1 (de) 2009-05-06
SI1474174T1 (sl) 2009-08-31
WO2003068267A1 (en) 2003-08-21
JP2005520816A (ja) 2005-07-14
CN101060862A (zh) 2007-10-24
RU2004124042A (ru) 2005-06-10
MXPA04007946A (es) 2005-06-08
CA2475025C (en) 2010-07-27
AU2003206355B2 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
BR0312427A (pt) Combinação, uso de uma combinação, método para a produção de um efeito inibitório de ibat em um animal de sangue quente, método de prevenção de diarréia, composição farmacêutica, método de tratamento de condições hiperlipidêmicas em um animal de sangue quente, e, uso de um sal metálico
DE60302348D1 (de) Verwendung von cyclopamine zur behandlung von psoriasis und anderen hauterkrankungen
FIC20130042I1 (fi) Fampridiini tai sen suola tai solvaatti
EE05423B1 (et) IL-18 inhibiitori kasutamine maksakahjustuse ja muude haiguste raviks v?i ennetamiseks sobiva ravimi valmistamiseks, vektori ja raku kasutamine inhibiitori produtseerimisel ning IL-18 inhibiitorit sisaldav farmatseutiline kompositsioon
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
DE60327511D1 (de) Zusammensetzung zur oralen oder rektalen verabreichung
DE602004012418D1 (de) Piperazinderivate und anwendungsverfahren
WO1995031991A3 (en) Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
ECSP055844A (es) Nuevos compuestos triciclicos
EP1178796A4 (de) Aminoimidazolcarboxamidesalze zur vorbeugung und behandlung von leberkrankheiten
EP1784173A4 (de) Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat-derivaten
MY140954A (en) Composition for oral or rectal administration
GR3032301T3 (en) N-hydroxyureas as antiinflammatory agents
DE60309465D1 (de) Behandlung oder prävention von urogenitaler atrophie und deren symptomen bei frauen
ATE369865T1 (de) Gerinnungshemmende zusammensetzung
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
PL375354A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis
DE60312154D1 (de) 2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten
EP2101809A4 (de) Pharmazeutische zusammensetzung mit arazym zur prävention von leberfunktionsstörung
FI20031793A0 (fi) Uusi anti-proliferatiivinen farmaseuttinen koostumus
UA49382A (uk) Спосіб лікування дерматозів
BR0314518A (pt) Sais de metal multivalente de ácidos borÈnicos e seus usos no tratamento de trombose
UA3173U (uk) Спосіб лікування первинної відкритокутової глаукоми
RU2004133618A (ru) Способ лечения воспалительных заболеваний женских половых органов
TH137782A (th) องค์ประกอบและวิธีการสำหรับ ป้องกันและรักษาโรคอัลไซเมอร์

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1474174

Country of ref document: EP